Deloitte Guan Huang Chen Fang Accountants
Cricket Square Hutchins Drive P.O. Box 2681 Grand Cayman KY1-1111 Cayman Islands
Head Office and Principal Place of Business
6 Fuk Wang Street, Yuen long Industrial Estate, New Territories, Hong Kong
Hong Kong motherboard
Federal Pharmaceutical International Holdings Co., Ltd. is an investment holding company, mainly engaged in the sale of intermediate products, API and preparation products. The company operates through three business units. The intermediate department is engaged in the business of selling intermediate products. The API Department is engaged in the business of selling APIs. The preparation products Department is engaged in the sales of antibiotic preparation products, non-antibiotic preparation products and hollow capsules. The company, through its subsidiaries, is also engaged in the manufacture and sale of organic fertilizers.
Federal Pharmaceutical was founded in Hong Kong in 1990. In 1994, Zhuhai Federal Pharmaceutical Co., Ltd. was established with an investment of hundreds of millions of Hong Kong dollars. With advanced pharmaceutical technology, scientific management, excellent service, and enthusiasm for serving the health of the Chinese people, Zhuhai Federal Pharmaceutical Co., Ltd. provides a wide range of products, especially antibiotic products, as well as raw materials and intermediates of these products, to promote the development of China's medical and health industry.
Federal Pharmaceutical has six production bases, including Hong Kong Federal Pharmaceutical Factory Co., Ltd. (preparation), Zhuhai Federal Pharmaceutical Co., Ltd. (raw materials), Zhongshan Branch of Zhuhai Federal Pharmaceutical Co., Ltd. (preparation), Federal Pharmaceutical Jinyi capsule Factory (hollow capsule), Federal Pharmaceutical (Inner Mongolia) Co., Ltd. (intermediate), Jingui Pharmaceutical Co., Ltd. (veterinary medicine). Federal Pharmaceutical integrates drug research and development, production and management, and integrates the production of pharmaceutical intermediates, raw materials, pharmaceutical preparations and drug packaging materials from biological fermentation to realize a vertically integrated production and management mode. with high-quality after-sales service network, perfect market information feedback system and rigorous quality assurance system, it has laid a solid foundation for the excellent product quality of Federal Pharmaceutical. On June 15, 2007, Federal Pharmaceutical International Holdings Co., Ltd. was successfully listed in Hong Kong, which indicates that Federal Pharmaceutical has stepped onto a new development platform to gain a foothold in Hong Kong, radiate the whole world, and expand its brand rapidly.
Federal Pharmaceutical has world-class production equipment. The annual production capacity is 1.54 billion capsules, 1.08 billion tablets, 115 million bags of granules, 20 million bags of suspensions, 20 million bottles of oral liquid, 130 million bottles of powder injection, 45 million bottles of ointment, 19.5 million bottles of freeze-dried powder injections, 24 million bottles of eye drops and 24 million bottles of insulin. the annual production capacity has jumped to a new level. Federal Pharmaceutical takes the lead in many products, including key high-tech enterprises of the National Torch Plan, high-tech enterprises of Guangdong Province, postdoctoral research workstations of Chinese pharmaceutical specialty, top 100 of China's pharmaceutical industry, and advanced collectives of Guangdong Province. each of the titles in the industry fully proves the comprehensive strength of Federal Pharmaceuticals. The first batch of domestic pharmaceutical enterprises that have passed the national GMP certification for all dosage forms at one time, the research and development of more than 160 kinds of drugs, the acquisition of hundreds of pharmaceutical approvals, and each valuable gold-lettered signboard fully reflect the leading level of federal pharmaceuticals.
Federal Pharmaceutical, as always, adhering to the commitment of "making life more valuable", strives to promote the development of China's medical and health industry and provide more high-quality and efficient pharmaceutical products for the society.